Seqirus Culture | Comparably
Comparably
Related Companies:CSLCSL BehringCSL Plasma
Seqirus Empresa reivindicada
Updated on: April 5, 2022

Seqirus Cultura da Companhia

Cultura Seqirus

Essa avaliação vem de colaboradores.
N/A
Rate Your Company

Dimensões de Cultura Mais Bem Avaliadas

N/A

CEO do Seqirus

Paul Perreault Seqirus' CEO
Paul Perreault
Avalie seu CEO

Veja Mais

Seqirus Missão Visão e Valores

Missão

At Seqirus, we are driven by just one goal - to lessen the severity and impact of influenza, which can reach epidemic or even pandemic proportions with life-threatening consequences. Every year our influenza vaccines help protect millions of people. We find solutions to big, complex, challenging problems, and we see the results in the world around us. Then we do it all over again the following year.

Valores

  • Patient Focus - We deliver on our promise to patients.
  • Innovation - We turn innovative thinking into solutions.
  • Integrity - We walk the talk.
  • Collaboration - We are stronger together.
  • Superior Performance - We take pride in our results.

Seqirus Cultura Num Relança

Seqirus has 3000 employees in 3 locations. 1 colaboradores na companhia Seqirus avaliaram Seqirus de vários tópicos como nível de exêcutivos e fluidez de trabalho,o mais recente foi mesesatrás.

Informação de Companhia

SL6 8AA HQ
Seqirus UK Limited Point, Level 3, 29 Market Street
SL6 8AA
United Kingdom
Cambridge HQ
50 Hampshire Street 9th Floor
Cambridge, MA 02139
United States Minor Outly
Holly Springs HQ
475 Green Oaks Parkway
Holly Springs, NC 27540
United States Minor Outly
Website
www.seqirus.com
Fundado
2015
Mídias Sociais

Descrição de Companhia

Seqirus, part of the CSL Group, is the new global company created from the combined strength and expertise of bioCSL and the influenza vaccines business formerly owned by Novartis. In July 2015, the two businesses joined forces to create Seqirus, now the second largest influenza vaccine company in the world. With extensive research and production expertise and manufacturing plants in the US, UK, Germany and Australia, Seqirus is a transcontinental partner in pandemic preparedness and a major contributor to the prevention and control of influenza globally. Seqirus has a workforce of over 3,000 employees, significant manufacturing capacity and a commercial presence in over 20 countries.

Executivos Chave

Nome e Título
Bio
Paul Perreault CEO / President
Paul Perreault
CEO / President
Mr Perreault has more than 35 years of experience across both the global biotech and pharmaceutical industries. He was appointed Chief Executive Officer and Managing Director of CSL Limited in July 2013, and was appointed to the CSL Board of Directors the same year. Since then, CSL has grown to become the third largest biotech company in the world with more than 25,000 employees bringing lifesaving medicines to people in more than 100 countries. Mr. Perreault, who previously served as CSL Behring’s President, joined CSL in 2004 with the acquisition of Aventis Behring. Prior to CSL, he spent more than 15 years in key senior roles at Wyeth-Ayerst Laboratories, now part of Pfizer. Mr. Perreault holds a bachelor degree in psychology from the University of Central Florida and completed advanced business management training at the Kellogg and Wharton schools of business.
John Minardo Vice President, General Counsel
John Minardo
Vice President, General Counsel
John Minardo serves as the Vice President, General Counsel of Seqirus. John started at Seqirus in Nov of 2015. John currently resides in the Greater New York City Area.
Brent MacGregor Senior Vice President, Global Commercial Operations, and President, Seqirus Inc.
Brent MacGregor
Senior Vice President, Global Commercial Operations, and President, Seqirus Inc.
Brent MacGregor serves as the Senior Vice President, Global Commercial Operations, and President, Seqirus Inc. of Seqirus. Brent currently resides in the Greater New York City Area.

Avise Seqirus Que você Quer trabalhar Lá

Avise Seqirus que você está Interessado em trabalhar para a companhia, ao mesmo tempo matenha a sua anônimidade. Comparably dará Seqirus a oportunidade de te contratar quando uma vaga com a sua cara aparecer!

Seqirus Visto H1B

In 2019, Seqirus aplicado por 4 vistos H1B. Das permissões de trabalho aplicadas, 100% foram aprovadas.

Resultado Permissão de Trabalho

Seqirus Tem um total de 3000 colaboradores

4
Total Aplicado
  • 100% Garantido (4 Fora de 4)
  • 0% Recusado ( Fora de 4)
  • 0% Retirado Processo foi cancelado pelo colaborador antes de aprovacão ( Fora de 4)
  • 0% Retirada Certificada Processo foi aprovado mas depois cancelado pelo candidato ( Fora de 4)

essa Informação foi Calculada com base em OFLC Performance Data

Pontuação de Gênero Quão positiva é avaliacão de mulheres sobre sua experiência de trabalho em Seqirus

N/A

Pontuação de Diversidade Quão positiva minorias avaliam sua experiência na empresa Seqirus

N/A

eNPS

Pontuacão de Rede leva seus colaboradores para essa questão: "On a scale from 0-10, Qual a probabilidade de você convidar um amigo para trabalhar aqui?"
0
eNPS Score
0%Promoters
100%Passives
0%Detractors

Seqirus Competidores

  1. 1st
    Sinovac Biotech
    0 / 100
  2. 2nd
    Seqirus
    0 / 100

Benefícios e Vantagens

Saúde e bem estar
Seguro dentário
Seguro de visão
Seguro de saúde
Seguro de vida
Tempo fora pago
PTO/ Política de férias
Férias pagas
Saída Maternidade/ Paternidade
Benefícios financeiros
Plano de aposentadoria
Reembolso de estudo
Compra de ações por funcionários
Vantagens do escritório
Política de trabalho em casa
Espaço de escritório único

Sabe de alguem que trabalha emSeqirus?

Enviar a eles uma mensagem para valiar a cultura da companhia

Envie um Convite anônimo

×
Rate your company